Ignite Creation Date:
2025-12-24 @ 7:49 PM
Ignite Modification Date:
2025-12-25 @ 5:26 PM
Study NCT ID:
NCT00829504
Status:
COMPLETED
Last Update Posted:
2009-09-11
First Post:
2009-01-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Ropinirole 0.25 mg Tablets Under Fasting Conditions
Sponsor:
Teva Pharmaceuticals USA
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-10
Start Date Type:
None
Primary Completion Date:
2004-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2004-10
Completion Date Type:
ACTUAL
First Submit Date:
2009-01-26
First Submit QC Date:
None
Study First Post Date:
2009-01-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-07-06
Results First Submit QC Date:
None
Results First Post Date:
2009-08-18
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2009-09-01
Last Update Post Date:
2009-09-11
Last Update Post Date Type:
ESTIMATED